Coloma Jason V sold $725K of MAZE (indirect holdings)
Coloma Jason V (Chief Executive Officer) sold 27,858 indirectly-held shares of Maze Therapeutics, Inc. (MAZE) at an average of $26.04 ($26.00–$26.05, $0.73M total) across 3 trades over 2026-06-22 to 2026-06-23 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The key new information is the disclosed sale size, timing, and that it was executed under a pre-arranged 10b5-1 plan; this typically has limited fundamental impact but can influence short-term sentiment.
Market read
Traders may briefly reassess positioning around MAZE due to insider selling, but the 10b5-1 structure reduces the likelihood of a strong negative signal.
What to watch
Indirect holdings and the post-transaction share count (319,079) may matter for interpreting whether the sale meaningfully changes economic exposure, but the article provides no additional context on total compensation or prior sale cadence.
Background
The article is an SEC Form 4 insider transaction disclosure for Maze Therapeutics, Inc., identifying the CEO and the nature of the sale.
Ticker impact
SEC Form 4 shows CEO Coloma Jason V sold $725.5K of MAZE via an open-market sale under a 10b5-1 plan (27,858 shares).
Low likelihood of a sustained price move; any impact is likely short-lived unless accompanied by other company-specific catalysts.
The disclosure is a Form 4 insider sale by the CEO, but it is explicitly pre-arranged under a Rule 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
Minimal; this is company-specific insider transaction data with no stated sector-wide regulatory/clinical catalyst.
None indicated.
None indicated.
Counterpoint
Because the sale is under a 10b5-1 plan, it may be mechanically scheduled and not a bearish read-through; traders may ignore it unless there’s a pattern of unusually large discretionary selling.
Key entities
- issuerMaze Therapeutics, Inc.
Subject of the Form 4 insider transaction; CEO sold shares totaling ~$725.5K at ~$26.04.
- insiderColoma Jason V
CEO and director; sold 27,858 shares across three trades (2026-06-22 to 2026-06-23) under a 10b5-1 plan.